Early initiation of ceftaroline-based combination therapy for methicillin-resistant Staphylococcus aureus bacteremia

Table 2 Unweighted and propensity-score weighted analysis of the primary outcome and its individual components

Outcome	Unadjusted Analysis^a		Unweighted regression	Propensity score-weighted regression
Outcome	Combination	Monotherapy	OR (95% CI)	OR (95% CI)
Primary Composite	41/95 (43)	29/118 (25)	2.23 (1.24, 4.01)	1.58 (0.60, 4.18)
Persistent bacteremia	18/95 (19)	8/118 (7)	--	4.28 (1.64, 11.19)
30-day mortality	25/95 (26)	21/118 (18)	--	1.00 (0.33, 3.08)
30-day recurrence	1/95 (1)	2/118 (2)	--	Not included^b

^aData are presented as No. (%)
^bNot included as too few patients had 30-day recurrence and therefore the model was unstable

ISSN: 1476-0711